Alleshausen, Germany

Reinhold J Buck

This inventor holds 27 USPTO granted patents and 2 published patent applications and 13 EPO patents, primarily in Membrane Technology. Top assignees: Gambro Lundia Ab, Gambro Dialysatoren Kg, Gambro Dialysatoren Gmbh & Co Kg. Active years: 1986-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reinhold J Buck. Retrieved from https://idiyas.com/inventor/reinhold-j-buck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.9

ph-index = 7

Forward Citations = 151(Granted Patents)


Location History:

  • Allerhausen, DE (1996)
  • Alleshausen, DE (1986 - 2024)

Company Filing History:


Years Active: 1986-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Hollow Fiber Membranes
Blood Purification
Capillary Dialyzer
Permselective Membrane
Filtration Device
Hydrophilic Membranes
Asymmetric Membranes
Plasmapheresis Membrane
Ultrafiltration Membranes
Separation Process
Heat-Sterilizable Membrane
27 patents (USPTO):Explore Patents

Title: **Reinhold J. Buck: Innovator in Membrane Technology**

Introduction

Reinhold J. Buck, an esteemed inventor residing in Alleshausen, Germany, is known for his remarkable contributions to the field of membrane technology. With a commendable portfolio of 26 patents, Buck has made significant strides in developing innovative solutions for blood purification and hollow fiber membranes.

Latest Patents

Among his latest inventions, Buck has developed a spinneret designed specifically for producing hollow fiber membranes through a phase inversion process. This spinneret plays a crucial role in enhancing the efficiency and functionality of membrane production. Additionally, he has created semipermeable membranes tailored for blood purification applications. These membranes exhibit a remarkable ability to remove larger molecules while effectively retaining albumin. Characterized by a molecular retention onset (MWRO) of between 9.0 kD and 14.5 kD and a molecular weight cut-off (MWCO) ranging from 55 kD to 130 kD, these membranes can be produced through industrially feasible processes that exclude salt treatments prior to drying. The invention extends to the process for membrane production and its medical applications, significantly advancing the field of hemodialysis.

Career Highlights

Throughout his career, Buck has been associated with reputable companies, including Gambro Lundia Ab and Gambro Dialysatoren Kg, where he has honed his expertise in membrane technology and its practical applications in medical devices. His innovations have positioned him as a leading figure in enhancing the quality of blood purification technology.

Collaborations

Buck has collaborated with notable peers in his field, including Arnd Wochner and Markus Storr. Working alongside these individuals has undoubtedly contributed to his success and the impactful nature of his patents in the medical field.

Conclusion

Reinhold J. Buck’s contributions to membrane technology and blood purification highlight his status as an influential inventor. With his extensive patent portfolio and collaborations, he continues to pave the way for advancements that enhance patient care and medical efficiency. His innovations not only reflect his expertise but also provide a glimpse into the future of medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…